Market research
8HH.F Avanos Medical, Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 1B
- P/E ratio
- Not available
- Analyst target
- 43
- Dividend yield
- Not available
- Beta
- 1.57
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- US05350V1061
- Market cap
- 1B
- P/E ratio
- Not available
- Analyst target
- 43
- Dividend yield
- Not available
- Beta
- 1.57
About
About Avanos Medical, Inc
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia. As of July 27, 2026, Avanos Medical, Inc. was taken private.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 8HH.F discussion.
5 years, 5 months ago
Avanos Medical, Inc is currently in a long term downtrend where the price is trading 13.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.9.
Avanos Medical, Inc's total revenue sank by 2.5% to $185M since the same quarter in the previous year.
Its net income has dropped by 673.8% to $-47M since the same quarter in the previous year.
Finally, its free cash flow grew by 63.6% to $-4M since the same quarter in the previous year.
Based on the above factors, Avanos Medical, Inc gets an overall score of 2/5.